美股市场个股详情

TEVA 梯瓦制药

添加自选

21.490
-0.110-0.51%

收盘价 01/08 16:00 (美东)

21.500
+0.010+0.05%

盘后 19:39 (美东)

243.49亿总市值-25.28市盈率TTM

关于梯瓦制药公司

梯瓦制药工业有限公司从事药品的开发、生产和销售。它通过以下地理部分运作:北美，欧洲和国际市场。

公司介绍

公司代码TEVA

公司名称梯瓦制药

上市日期2012/05/30

成立日期1901

CEOMr. Richard D. Francis

所属市场纽交所

员工数量37851

证券类型存托凭证

ADS转换比例1.0 : 1.0

年结日12-31

公司地址124 Dvora HaNevi'a Street

城市特拉维夫

省份特拉维夫

国家以色列

邮编6944020

电话972-3-914-8213

网址http://www.tevapharm.com

董事高管

姓名
职务
年薪

Richard D. Francis
Director, President and Chief Executive Officer
--

Eric A Hughes
Executive Vice President, Global R&D and Chief Medical Officer
--

Amir Weiss
Senior Vice President and Chief Accounting Officer
--

Eli Kalif
Executive Vice President and Chief Financial Officer
494.38万

David R. McAvoy
Executive Vice President and Chief Legal Officer
--

Richard Daniell
Executive Vice President, European Commercial
516.42万

Angus Grant
Executive Vice President, Business Development
--

Christine Fox
Executive Vice President, U.S. Commercial
--

Mark Sabag
Executive Vice President, International Markets Commercial
372.91万

Matthew Shields
Executive Vice President, Global Operations
--

Dr. Sol J. Barer,PhD
Chairman of the Board
54.00万

Dr. Tal Zaks, M.D.,PhD
Independent Director
33.00万

Chen Lichtenstein
Independent Director
--

Gerald M. Lieberman
Independent Director
35.50万

Professor Ronit Satchi-Fainaro
Independent Director
31.52万

Professor Varda Shalev
Independent Director
17.67万

Dr. Perry D. Nisen
Independent Director
32.79万

Roberto A. Mignone
Independent Director
34.00万

Amir Elstein
Independent Director
34.00万

Rosemary A. Crane, M.B.A.
Independent Director
33.00万

Janet S. Vergis
Independent Director
32.55万

Vikki L. Conway
Acting Head of Global Human Resources
--

美股市场投资机会

代码迷你走势涨跌幅

解锁榜首股票

相关主题投资

流行病诊疗

流行病诊疗